P-033 Real world evaluation of teclistamab in patients with RRMM: results from the IMF immunotherapy database project

Yi Lin; Sireesha Asoori Maringanti; Efstathios Kastritis; Joaquín Martínez‐López; Larissa Brunaldi; Radhika Bansal; Despina Fotiou; Magdelana Corona; Reyes Mas; Andre De Menezes Silva Corraes; Prashant Kapoor; Meletios A Dimopoulos; Andre Tamayo; Sikander Ailawadhi; Ricardo Parrondo; Brian G.M. Durie; Thomas G. Martin

doi:10.1016/s2152-2650(23)01651-8

Article2023

Real-World Evaluation of Teclistamab for the Treatment of Relapsed/Refractory Multiple Myeloma (RRMM)

Sireesha Asoori, Rakesh Popat, Joaquín Martínez‐López, Efstathios Kastritis, Larissa Brunaldi, Radhika Bansal, Andre De Menezes Silva Corraes, Kwee Yong, Catriona Mactier, Magdalena Corona, Adolfo Jesús Sáez Marín, Despina Fotiou, Meletios A Dimopoulos, Saurabh Chhabra, Sikander Ailawadhi, Ricardo Parrondo, Thomas G. Martin, Brian G.M. Durie, Yi Lin

Article2023

MM-527 Real World Evaluation of Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma (RRMM)

Sireesha Asoori Maringanti, Yi Lin, Stathis Estritis, Joaquín Martínez‐López, Radhika Bansal, Despina Fotiou, Magdalena Corona, Saurabh Chhabra, Larissa Brunaldi, Andre De Menezes Silva Corraes, Ricardo Parrondo, Prashant Kapoor, Sikander Ailawadhi, Reyes Mas, Andrea Tamayo, Meletios A Dimopoulos, Brian G.M. Durie, Thomas G. Martin

Article2023

POSTER: MM-527 Real World Evaluation of Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma (RRMM)

Sireesha Asoori Maringanti, Yi Lin, Stathis Estritis, Joaquín Martínez‐López, Radhika Bansal, Despina Fotiou, Magdalena Corona, Saurabh Chhabra, Larissa Brunaldi, Andre De Menezes Silva Corraes, Ricardo Parrondo, Prashant Kapoor, Sikander Ailawadhi, Reyes Mas, Andrea Tamayo, Meletios A Dimopoulos, Brian G.M. Durie, Thomas G. Martin

Article2025

Outcomes of frailty subgroups of older adults (age ≥ 70) treated with teclistamab: an International Myeloma Foundation immunotherapy database real-world analysis

Hira Mian, Thomas G Martin, Gregory R. Pond, Sireesha Asoori, Rakesh Popat, Efstathios Kastritis, Joaquín Martínez‐López, Nadine Abdallah, Saurabh Chhabra, Ricardo Parrondo, Sikander Ailawadhi, Meletios A Dimopoulos, Kwee Yong, Brian GM. Durie, Saad Z. Usmani, Yi Lin, Carlyn Tan

Article2025

Real-world evaluation of teclistamab for the treatment of relapsed/refractory multiple myeloma (RRMM): an International Myeloma Working Group Study

Carlyn Tan, Sireesha Asoori, Chiung‐Yu Huang, Larissa Brunaldi, Rakesh Popat, Efstathios Kastritis, Joaquín Martínez‐López, Radhika Bansal, Andre De Menezes Silva Corraes, Saurabh Chhabra, Ricardo Parrondo, Sikander Ailawadhi, Despina Fotiou, Meletios A Dimopoulos, Kwee Yong, Catriona Mactier, Chris Lau, Magdalena Corona, Adolfo Sáez, Hira Mian, Brian G.M. Durie, Saad Z. Usmani,

P-033 Real world evaluation of teclistamab in patients with RRMM: results from the IMF immunotherapy database project

Discussion(0)

Related publications

Real-World Evaluation of Teclistamab for the Treatment of Relapsed/Refractory Multiple Myeloma (RRMM)

MM-527 Real World Evaluation of Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma (RRMM)

POSTER: MM-527 Real World Evaluation of Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma (RRMM)

Outcomes of frailty subgroups of older adults (age ≥ 70) treated with teclistamab: an International Myeloma Foundation immunotherapy database real-world analysis

Real-world evaluation of teclistamab for the treatment of relapsed/refractory multiple myeloma (RRMM): an International Myeloma Working Group Study